Autoimmunological serum parameters and bone mass density in premature ovarian insufficiency: a retrospective cohort study
Authors:
Open Access
- 9 November 2020
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 303 (4) , 1109-1115
Abstract
Purpose: It is still not clear whether to screen women with primary premature ovarian insufficiency for autoimmunity. Moreover, a possible association of autoimmunity with decreased bone mass density in premature ovarian insufficiency patients has not been evaluated. Thus, the objectives of this study were to review our experience with the use of an autoimmune screening panel in premature ovarian insufficiency women and to focus on bone mass density. Methods: In a retrospective cohort study, 76 chromosomally normal women with primary premature ovarian insufficiency were included. The main outcome parameters were the results of an autoimmune screening panel and of dual-energy X-ray absorptiometry. Results: Median age was 33 years. Sixty percent of premature ovarian insufficiency patients revealed abnormal dual-energy X-ray absorptiometry results (minimal T-score < −1.0). Any signs of autoimmunity were found in 21 women (36.2%). The most frequent abnormal results were increased thyroperoxidase antibodies (24.1%) and thyroglobulin antibodies (20.7%). A longer duration of amenorrhea (β = −0.015; p = 0.007), any abnormality during autoimmune screening (β = −0.940; p = 0.010), and a lower body mass index (β = −0.057; p = 0.036) were associated with a lower minimal T-score. Conclusion: In chromosomally normal women with primary premature ovarian insufficiency, the prevalence of autoimmunity and decreased bone mass density seem high. Our data highlight the association between autoimmune abnormalities and decreased dual-energy X-ray absorptiometry results.Keywords
Funding Information
- Medical University of Vienna
This publication has 35 references indexed in Scilit:
- Fragile X syndrome: causes, diagnosis, mechanisms, and therapeuticsJournal of Clinical Investigation, 2012
- Bone-Density Testing Interval and Transition to Osteoporosis in Older WomenNew England Journal of Medicine, 2012
- EMAS position statement: Managing women with premature ovarian failureMaturitas, 2010
- Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)Vascular Health and Risk Management, 2010
- Bone Mineral Density in Estrogen-Deficient Young WomenThe Journal of Clinical Endocrinology & Metabolism, 2009
- Dehydroepiandrosterone for systemic lupus erythematosusCochrane Database of Systematic Reviews, 2007
- Premature ovarian failure: Think ?autoimmune disorder?Sexuality, Reproduction and Menopause, 2004
- Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent FracturesArchives of internal medicine (1960), 2004
- Bone Loss in Young Women With Karyotypically Normal Spontaneous Premature Ovarian FailureObstetrics & Gynecology, 1998
- Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk factor for osteoporosis?Clinical Endocrinology, 1993